View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Malvern Panalytical|4 October 2018

Malvern Viscosizer TD with Taylor Dispersion Analysis

Malvern Viscosizer TD uses Taylor dispersion analysis for automated biophysical characterization.

Malvern Viscosizer TD offers ultra-low volume, solution-based molecular size and stability measurement capabilities.

Malvern Viscosizer TD uses Taylor dispersion analysis for automated biophysical characterization.

The tool provides ultra-low volume, solution-based molecular size and stability measurement capabilities.

The device also uses Poiseuille flow for relative viscosity assessment.

Viscosizer TD provides an orthogonal technique for conformational stability analysis to extend into label-free measurements in highly complex solutions, and encompasses a critical size range from small molecules through to protein-based systems.

Viscosizer TD features UV area imaging in microcapillary flow for ultra-low volume biophysical characterization of target biomolecules in solution.

Taylor dispersion analysis is a simple experimental method, where a nanoliter volume sample pulse is injected into a laminar flow of matched buffer.

Analysis of the time-evolved concentration profile, or Taylorgram, from UV absorption allows the molecular diffusion coefficient and hydrodynamic radius of solute molecules to be determined.

Viscosizer TD uses fully automated methodology to analyze stability of small molecules, peptides, proteins and samples with mixtures of these species in the presence of excipients and surfactants that can interfere in other techniques.

Microcapillary flow methodology allows complementary relative viscosity measurement on the same sample using Poiseuille’s law.

The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued...
The age of the battery is well underway. Lithium-ion batteries, for example, have already revolutionized our day-to-day lives – from smart mobile devices to pollution-free...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena